Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
(PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1
Debio 1143 in Combination With Carboplatin and Paclitaxel in Patient With Advanced Solid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE1
A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)
- Status
- COMPLETED
- Phase
- PHASE1
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma
- Status
- RECRUITING
- Phase
- PHASE2
Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin
- Status
- TERMINATED
- Phase
- PHASE2
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2